Dashboard
Manage Tickers

ADAGAdagene Inc.

Nasdaq adagene.com


$ 3.44 $ 0.50 (16.72 %)    

Friday, 13-Sep-2024 15:57:38 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 474.86 $ 2.12 (0.45 %)
DIA $ 414.87 $ 2.97 (0.72 %)
SPY $ 561.82 $ 2.92 (0.52 %)
TLT $ 100.40 $ 0.27 (0.27 %)
GLD $ 238.66 $ 2.35 (0.99 %)
$ 3.49
$ 3.20
-- x --
-- x --
$ 3.20 - $ 3.44
$ 1.21 - $ 4.38
118,812
na
153.97M
$ 0.64
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

adagene-h1-eps-026
Adagene H1 EPS $(0.26)
07/25/2024 20:41:52

Adagene (NASDAQ:ADAG) reported quarterly losses of $(0.26) per share.

hc-wainwright--co-reiterates-buy-on-adagene-maintains-5-price-target
HC Wainwright & Co. Reiterates Buy on Adag...
07/22/2024 10:23:30

HC Wainwright & Co. analyst Arthur He reiterates Adagene (NASDAQ:ADAG) with a Buy and maintains $5 price target.

hc-wainwright--co-reiterates-buy-on-adagene-maintains-5-price-target
HC Wainwright & Co. Reiterates Buy on Adag...
06/28/2024 11:11:15

HC Wainwright & Co. analyst Arthur He reiterates Adagene (NASDAQ:ADAG) with a Buy and maintains $5 price target.

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
05/31/2024 20:32:51

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
04/01/2024 16:31:03

Core News & Articles
Adagene Announced Progress, Expansion Of T...
02/09/2024 11:03:14

Interim data from additional MSS CRC patients dosed at 10 mg/kg every three weeks (Q3W) in combination with pembrolizumab antic...

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
02/01/2024 21:31:08

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
01/22/2024 21:31:12

why-transcode-therapeutics-shares-are-trading-lower-by-over-24-here-are-other-stocks-moving-in-fridays-mid-day-session
Why TransCode Therapeutics Shares Are Trad...
01/19/2024 18:05:18

Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,...

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
01/19/2024 17:31:10

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
01/18/2024 13:05:59

how-is-the-market-feeling-about-adagene
How Is The Market Feeling About Adagene?
01/18/2024 13:00:18

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
01/17/2024 21:31:08

why-airspan-networks-shares-are-trading-higher-by-over-380-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why Airspan Networks Shares Are Trading Hi...
01/17/2024 18:12:57

Shares of Airspan Networks Holdings Inc. (NASDAQ: MIMO) shares rose sharply during Wednesday’s session after the company announ...

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
01/17/2024 17:31:12

why-is-cancer-focused-adagene-stock-plummeting-today
Why Is Cancer Focused Adagene Stock Plumme...
01/17/2024 16:38:05

Adagene presents results at ASCO 2024 Gastrointestinal Cancers Symposium. ADG126, combined with Merck's Keytruda, shows lim...

why-datchat-shares-are-trading-lower-by-around-33-here-are-20-stocks-moving-premarket
Why DatChat Shares Are Trading Lower By Ar...
01/17/2024 13:18:56

Shares of DatChat, Inc. (NASDAQ: DATS) fell sharply in pre-market trading after announcing a proposed underwritten public offe...

adagene-announces-interim-results-from-masked-anti-ctla-4-safebody-adg126-in-combination-with-pembrolizumab-in-metastatic-microsatellite-stable-colorectal-cancer
Adagene Announces Interim Results From Mas...
01/16/2024 22:11:24

- Data from first tranche of MSS CRC patients treated with ADG126 10 mg/kg every three weeks (Q3W) in dose expansion showed cli...

adagene-will-present-interim-results-of-masked-anti-ctla-4-safebody-adg126-muzastotug-in-combination-with-pembrolizumab-in-mss-crc-at-american-society-of-clinical-oncology-2024-gastrointestinal-cancers-symposium
Adagene Will Present Interim Results of Ma...
01/04/2024 10:03:13

adagene-presents-data-demonstrating-the-best-in-class-therapeutic-index-for-masked-anti-ctla-4-safebody-adg126-at-sitc-2023
Adagene Presents Data Demonstrating The Be...
11/03/2023 16:07:03

- MSS CRC case examples reinforce optimal dosing regimen in ongoing phase 2 dose expansion, with a confirmed partial response a...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION